Skip to main content
. Author manuscript; available in PMC: 2010 Jan 27.
Published in final edited form as: Drug Metab Dispos. 2008 Aug 25;36(11):2211–2218. doi: 10.1124/dmd.108.022863

Fig. 5.

Fig. 5

Product ion (m/z 501) spectra. Each spectrum reflects the organic-soluble metabolites generated during incubation of 750 μM 6-hydroxywarfarin (A), 7-hydroxywafarin (B), or 8-hydroxywarfarin (C) with UGT1A10 or UGT1A10 F90A, F93A, or V92A in the presence of UDP-glucuronic acid (4 mM). Reversed phase-HPLC chromatograph of product ion (m/z 501) experiments. Each substrate was incubated individually for 180 min. All other incubation conditions are noted in Materials and Methods.